Jane Chang is a Senior Director of health economics and outcomes research (HEOR) in Oncology at Pfizer. Jane co-leads Work Package 4. She has over 15 years of experience HEOR within the pharmaceutical industry supporting products in a broad range of therapeutic areas including Oncology, Neuroscience, Dermatology, and Rheumatology in both global and US roles. Jane graduated from University of Michigan, Ann Arbor, with both her BS in Microbiology and MPH in Health Management and Policy.  She then completed a 2-year outcomes research fellowship with Duke University and Novartis before being employed at Novartis and later at Bayer.  In her 8 and half years at Bayer, Jane implemented market access strategy and HEOR plans for multiple oncology compounds in development and also during product launch.  She has received multiple recognition awards at Bayer for her leadership and team work.  At Pfizer, Jane has been supporting an Alliance immuno-oncology compound for the past 5 years leading the HEOR strategy and plans for several indications including implementing PROs into clinical trials.